Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.
Trump has pledged to protect Social Security and Medicare throughout his campaign, one analyst noted, but this was the first ...
GE HealthCare announced a $138 million investment to expand its contrast media fill/finish manufacturing site in Cork, ...
The inhaled mebufotenin candidate, dubbed GH001, was evaluated in the midstage study of 81 patients with treatment-resistant depression. The 40 patients who received GH001 saw an average 15.2 point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback